Detalles de la búsqueda
1.
Anticancer Drugs-Related Hypogonadism in Male Patients with Advanced Cancers on Active Treatment: A Systematic Review.
Oncologist
; 29(6): e728-e740, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38518107
2.
The Prognostic Nutritional Index in patients with microsatellite instability-high metastatic gastric or gastroesophageal cancers receiving immune checkpoint inhibitors.
Dig Liver Dis
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38772790
3.
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.
Ther Adv Med Oncol
; 15: 17588359231165978, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37063779
4.
EU health co-design policies to counteract the COVID-19 pandemic effect promoting physical activity.
Int J Risk Saf Med
; 33(2): 133-144, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35147565
5.
Paraneoplastic neurological syndromes in patients affected by SCLC: a case series.
Tumori
; 108(6): NP11-NP14, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260015
6.
Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications.
Ther Adv Med Oncol
; 14: 17588359221079123, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35281350
7.
Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy.
JCO Precis Oncol
; 6: e2200037, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35544729
8.
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients.
Ther Adv Med Oncol
; 13: 17588359211006960, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33948122
9.
The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab.
Cancers (Basel)
; 13(8)2021 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33921727
Resultados
1 -
9
de 9
1
Próxima >
>>